Imaging of the interaction of cancer cells and the lymphatic system

Advanced Drug Delivery Reviews

Volumn 63, Issue 10-11, 2011, Pages 886-889

  Cao, Hop S Tran ^a   McElroy, Michele ^a   Kaushal, Sharmeela ^b   Hoffman, Robert M ^a,b,c   Bouvet, Michael ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c ANTICANCER INC   (United States)

Author keywords

Antibody fluorophore conjugate; Cancer cell; Lymphatic delivery

Indexed keywords

ANTIBODY-FLUOROPHORE CONJUGATE; CANCER CELLS; CANCER METASTASIS; FLUORESCENCE IMAGING; FLUORESCENT PROTEIN; IN-VIVO; LYMPHATIC DELIVERY; LYMPHATIC SYSTEMS; REAL TIME; THERAPEUTIC AGENTS;

ANTIBODIES; CELLS; FLUORESCENCE; FLUOROPHORES; VISUALIZATION;

DISEASES;

CYANINE DYE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUORESCENT DYE; GREEN FLUORESCENT PROTEIN; ISOSULFAN BLUE; MANNOSE; MONOCLONAL ANTIBODY; PENTETIC ACID; RED FLUORESCENT PROTEIN; TECHNETIUM SULFUR COLLOID TC 99M; TRASTUZUMAB; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

BREAST CANCER; CANCER CELL; CANCER INVASION; CANCER STAGING; CELL INTERACTION; CELL LABELING; CELL MIGRATION; CELL PROLIFERATION; DRUG TARGETING; FLUORESCENCE IMAGING; HUMAN; IN VIVO STUDY; ISOTOPE LABELING; LYMPH NODE METASTASIS; LYMPHANGIOGRAPHY; LYMPHATIC SYSTEM; LYMPHOSCINTIGRAPHY; MELANOMA; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE;

ANIMALS; ANTIBODIES; DIAGNOSTIC IMAGING; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LYMPHATIC METASTASIS; LYMPHATIC SYSTEM; NEOPLASMS;

EID: 80052139632     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2011.05.015     Document Type: Review

References (15)

1. Torabi M., Aquino S.L., Harisinghani M.G. Current concepts in lymph node imaging. J. Nucl. Med. 2004, 45:1509-1518.
2. Cochran A.J., Essner R., Rose D.M., Glass E.C. Principles of sentinel lymph node identification: background and clinical implications. Langenbecks Arch. Surg. 2000, 385:252-260.
3. Mariani G., Moresco L., Viale G., Villa G., Bagnasco M., Canavese G., Buscombe J., Strauss H.W., Paganelli G. Radioguided sentinel lymph node biopsy in breast cancer surgery. J. Nucl. Med. 2001, 42:1198-1215.
4. Wallace A.M., Hoh C.K., Vera D.R., Darrah D.D., Schulteis G. Lymphoseek: a molecular radiopharmaceutical for sentinel node detection. Ann. Surg. Onc. 2003, 10:531-538.
5. Weinstein J.N., Parker R.J., Keenan A.M., Dower S.K., Morse H.C., Sieber S.M. Monoclonal antibodies in the lymphatics: toward the diagnosis and therapy of tumor metastases. Science 1982, 218:1334-1337.
6. Weinstein J.N., Stellar M.A., Keenan A.M., Covell D.G., Key M.E., Sieber S.M., Oldham R.K., Hwang K.M., Parker R.J. Monoclonal antibodies in the lymphatics: selective delivery to lymph node metastases of a solid tumor. Science 1983, 222:423-426.
7. Sharma R., Wang W., Rasmussen J.C., Joshi A., Houston J.P., Adams K.E., Cameron A., Ke S., Kwon S., Mawad M.E., Sevick-Muraca E.M. Quantitative imaging of lymph function. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H3109-H3118.
8. Licha K., Debus N., Emig-Vollmer S., Hofmann B., Hasbach M., Stibenz D., Sydow S., Schirner M., Ebert B., Petzelt D., Bührer C., Semmler W., Tauber R. Optical molecular imaging of lymph nodes using a targeted vascular contrast agent. J. Biomed. Opt. 2005, 10:41205.
9. Sampath L., Wang W., Sevick-Muraca E.M. Near infrared fluorescent optical imaging for nodal staging. J Biomed. Opt. 2008, 13:041312.
10. Yeon C.H., Pegram M.D. Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer. Invest. New Drugs 2005, 23:391-409.
11. He Y., Rajantie I., Ilmonen M., Makinen T., Karkkainen M.J., Haiko P., Salven P., Alitalo K. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res. 2004, 64:3737-3740.
12. Kadambi A., Mouta Carreira C., Yun C.O., Padera T.P., Dolmans D.E., Carmeliet P., Fukurama D., Jain R.K. Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular function and leukocyte recruitment: role of VEGF-receptor 2 and host VEGF-A. Cancer Res. 2001, 61:2404-2408.
13. Hoshida T., Isaka N., Hagendoorn J., di Tomaso E., Chen Y.L., Pytowski B., Fukumura D., Padera T.P., Jain R.K. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res. 2006, 66:8065-8075.
14. Hayashi K., Jiang P., Yamauchi K., Yamamoto N., Tsuchiya H., Tomita K., Moossa A.R., Bouvet M., Hoffman R.M. Real-time imaging of tumor-cell shedding and trafficking in lymphatic channels. Cancer Res. 2007, 67:8223-8228.
15. McElroy M., Hayashi K., Garmy-Susini B., Kaushal S., Varner J.A., Moossa A.R., Hoffman R.M., Bouvet M. Fluorescent LYVE-1 antibody to image dynamically lymphatic trafficking of cancer cells in vivo. J. Surg. Res. 2009, 151:68-73.